Dana Lynch | Investor Relations and Corporate Communications |
Peter Greenleaf | President and Chief Executive Officer |
Joe Miller | Chief Financial Officer |
Max Colao | Chief Commercial Officer |
Neil Solomons | Chief Medical Officer |
Alethia Young | Cantor Fitzgerald |
Ed Arce | H.C. Wainwright and Company |
Farzin Haque | Jefferies |
Ken Cacciatore | Cowen and Company |
Joseph Schwartz | SVB Leerink |
Justin Kim | Oppenheimer and Company |
David Martin | Bloom Burton |
Doug Miehm | RBC Capital Markets |
Greetings, and welcome to Aurinia Pharmaceuticals Third Quarter 2021 Results Conference Call. At this time all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Dana Lynch, Aurinia's Investor Relations and Corporate Communications.